Mikami et al. explored the level of PD-1 and programmed death ligand 1 (PD-1L) in tumor-infiltrating immune cells in the tumor microenvironment of untreated and VEGF-TKI-treated primary ccRCC tissues. This evidence concerns the gene VEGFA and neoplasm.